Literature DB >> 20654226

[Analysis of stomach cancer mortality in the national retrospective sampling survey of death causes in China, 2004 - 2005].

Xiao-Nong Zou1, Ji-Jun Duan, Xiao-Mei Huangfu, Wan-Qing Chen, Ping Zhao.   

Abstract

OBJECTIVE: To understand the current epidemiological characteristics as well as the trends of stomach cancer deaths in China.
METHODS: The data of stomach cancer mortalities in 2004 - 2005, from 158 sampling areas in the Third National Retrospective Sampling Survey of Death Causes in China, were analyzed and compared with the results from previous two national surveys.
RESULTS: The crude and age-standardized death rates of stomach cancer were 24.71/100 000 (35 250/142 660 482) and 16.16/100 000, respectively, accounted for 18.19% (35 250/193 841) and ranking third of cancer causes in the national sampling areas of China in 2004 - 2005. Those crude death rate increased by 42.01% while the age-standardized death rate decreased by 8.70% compared to the results in 1973 - 1975 (17.40/100 000 and 17.70/100 000), and both decreased 1.79% and 25.74% from 1990 - 1992 (25.16/100 000 and 21.76/100 000), respectively. For urban residents of the sampling areas, the crude and age-standardized death rates of stomach cancer were 22.98/100 000 (11 005/47 899 806) and 13.63/100 000, accounted for 15.03% (11 005/71 936) of cancer causes in 2004 - 2005, which increased by 18.21% and decreased by 31.16% from 1973 - 1975 (19.44/100 000 and 19.80/100 000), and increased by 18.21% and decreased by 11.15% from 1990 - 1992 (19.44/100 000 and 15.34/100 000), respectively. While for rural residents in the sampling areas, the crude and age-standardized death rates were 25.59/100 000 (24 245/94 760 676) and 17.64/100 000, accounted for 19.89% (24 245/121 905) of cancer causes, both increased by 53.97% and 3.76% from 1973 - 1975 (16.62/100 000 and 17.00/100 000), and both decreased by 5.78% and 27.59% from 1990 - 1992 (27.16/100 000 and 24.36/100 000), respectively.
CONCLUSION: The current stomach cancer is still one of predominant cancers in China. The consistently substantial decreases in age-standardized death rates of stomach cancer might prompt the beneficial impact on reducing the risks for that cancer by the social economical development during recent decades in China.

Entities:  

Mesh:

Year:  2010        PMID: 20654226

Source DB:  PubMed          Journal:  Zhonghua Yu Fang Yi Xue Za Zhi        ISSN: 0253-9624


  16 in total

1.  The role of B7-H1 in gastric carcinoma: clinical significance and related mechanism.

Authors:  Dong Jiang; Yun-yun Xu; Fang Li; Biao Xu; Xue-guang Zhang
Journal:  Med Oncol       Date:  2014-10-14       Impact factor: 3.064

2.  Comparative epidemiology of gastric cancer between Japan and China.

Authors:  Yingsong Lin; Junko Ueda; Shogo Kikuchi; Yukari Totsuka; Wen-Qiang Wei; You-Lin Qiao; Manami Inoue
Journal:  World J Gastroenterol       Date:  2011-10-21       Impact factor: 5.742

3.  Paeoniflorin inhibits human gastric carcinoma cell proliferation through up-regulation of microRNA-124 and suppression of PI3K/Akt and STAT3 signaling.

Authors:  Yong-Bin Zheng; Gao-Chun Xiao; Shi-Lun Tong; Yu Ding; Qiu-Shuang Wang; Sheng-Bo Li; Zhi-Nan Hao
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

4.  Risk factors for under-diagnosis of gastric intraepithelial neoplasia and early gastric carcinoma in endoscopic forceps biopsy in comparison with endoscopic submucosal dissection in Chinese patients.

Authors:  Guifang Xu; Weijie Zhang; Ying Lv; Bin Zhang; Qi Sun; Tingsheng Ling; Xiaoqi Zhang; Zhihua Zhou; Lei Wang; Qin Huang; Xiaoping Zou
Journal:  Surg Endosc       Date:  2015-09-30       Impact factor: 4.584

5.  Silencing of FRAT1 by siRNA inhibits the proliferation of SGC7901 human gastric adenocarcinoma cells.

Authors:  Qinggong Yu; L U Shang; Hongbo Yu; Zirong Yang; Dekui Xu
Journal:  Biomed Rep       Date:  2016-01-11

6.  The Expression of MCM7 is a Useful Biomarker in the Early Diagnostic of Gastric Cancer.

Authors:  Jing-Yan Yang; Dong Li; Yuan Zhang; Bing-Xin Guan; Ping Gao; Xing-Chen Zhou; Cheng-Jun Zhou
Journal:  Pathol Oncol Res       Date:  2017-05-25       Impact factor: 3.201

7.  The PIWI protein acts as a predictive marker for human gastric cancer.

Authors:  Yang Wang; Yanxia Liu; Xiaoying Shen; Xiaoyan Zhang; Ximei Chen; Changqin Yang; Hengjun Gao
Journal:  Int J Clin Exp Pathol       Date:  2012-04-19

8.  Impact of neoadjuvant chemotherapy on lymphocytes and co-inhibitory B7-H4 molecule in gastric cancer: low B7-H4 expression associates with favorable prognosis.

Authors:  Ninu Maskey; Kai Li; Min Hu; Zhigao Xu; Chunwei Peng; Fang Yu; Hong Cao; Jiamei Chen; Yan Li; Guifang Yang
Journal:  Tumour Biol       Date:  2014-09-27

9.  The human epididymis protein 4 acts as a prognostic factor and promotes progression of gastric cancer.

Authors:  Yun-Di Guo; Jing-Hao Wang; Huan Lu; Xiao-Ning Li; Wei-Wei Song; Xiao-Dan Zhang; Wen-Ming Zhang
Journal:  Tumour Biol       Date:  2014-11-29

10.  [Epidemiology of gastric cancer: experience of a Moroccan hospital].

Authors:  Ihsane Mellouki; Nawal Laazar; Bahija Benyachou; Nouredine Aqodad; Adil Ibrahimi
Journal:  Pan Afr Med J       Date:  2014-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.